An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002
Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995
Central Nervous System Metastases from Non-Hodgkin's Lymphoma:Treatment & Prophylaxis
Am J Med 84:425-435, Recht,L.,et al, 1988
Comparison of Intermed Dose Methotrexate with Cranial Irrad for the Post-Induc Treat. of Acute Lymph. Leuk. in Children
NEJM 308:477-484, Freeman,A.I.,et al, 1983
Long-term Neurological Implications of Somnolence Syndrome in Children with Acute Lymphocyte Leukemia
Ann Neurol 8:273-277, Ch'ien,L.T.,et al, 1980
Abnor CT Scans of Brain in Asympt. Chil with Acute Lymph. Leuk. after Prophy. Treat of CNS with Radia & Intrathe Chemo
NEJM 298:815, Peylan-Ramu,N.,et al, 1978